Endocrine Abstracts

Background: Renal neuroendocrine tumors (NETs) are a particularly rare subset of NETs, with fewer than 100 cases described in the literature. Of these, next generation sequencing (NGS) findings have been described in fewer than 10 cases, all but one of which had grade 1 disease.Methods: A single-center, IRB-approved retrospective analysis of patients with grade 2 or 3 well-differentiated renal NETs treated at our institution from 2016-2023 for whom NGS d...